International Myeloma Foundation Responds to ICER Report

The International Myeloma Foundation (IMF) recently spoke out against the Institute for Clinical and Economic Review’s (ICER) report on the value of myeloma drugs. Find out what IMF had to say here. (Source: Journal of Clinical Pathways, 5/26/16)

You might also be interested in:

Review of Influence: The Institute for Clinical and Economic Review February 26, 2019
ICER Releases Report on Plaque Psoriasis Treatments April 28, 2018
New ICER Report Reviews Elagolix for Endometriosis May 5, 2018
ICER Sets Out Against Unjustified Price Increases in New Report February 7, 2019
ICER Using New Economic Modeling Platform for Value Assessment August 24, 2018
ICER Posts Draft Scoping Document on Medication-Assisted… April 28, 2018
ICER Releases Report on Therapies for Long-term Prophylaxis HAE November 16, 2018